Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
26.06.2024 |
20.06.2024 |
14.06.2024 |
10.06.2024 |
07.06.2024 |
06.06.2024 |
04.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
0.4675
|
0.4675
|
0.595
|
0.55
|
|
|
101 283.37
|
170.00
|
|
0.4698
|
0.41
|
0.41
|
0.41
|
0.41
|
|
|
398.11
|
11.00
|
|
0.4698
|
0.4575
|
0.40
|
0.4675
|
0.40
|
|
|
216.10
|
6.00
|
|
0.4698
|
0.38
|
0.38
|
0.4012
|
0.38
|
|
|
4 474.82
|
91.00
|
|
0.4698
|
0.4775
|
0.41
|
0.4781
|
0.43
|
|
|
1 619.87
|
19.00
|
|
0.5538
|
0.52
|
0.52
|
0.52
|
0.52
|
|
|
1 299.48
|
14.00
|
|
0.6479
|
0.51
|
0.48
|
0.52
|
0.52
|
|
|
8 383.19
|
13.00
|
|
0.6479
|
0.555
|
0.51
|
0.555
|
0.51
|
|
|
1 340.58
|
4.00
|
0.5524
|
|
0.5975
|
0.56
|
0.5975
|
0.56
|
|
|
4 650.27
|
4.00
|
0.5351
|
|
0.6475
|
0.6475
|
0.65
|
0.65
|
|
|
2 626.23
|
29.00
|
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.